BlackRock’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.63B | Sell |
12,954,765
-1,727,629
| -12% | -$217M | 0.03% | 452 |
|
2025
Q1 | $1.62B | Sell |
14,682,394
-100,328
| -0.7% | -$11.1M | 0.03% | 444 |
|
2024
Q4 | $2.02B | Buy |
14,782,722
+526,674
| +4% | +$71.9M | 0.04% | 383 |
|
2024
Q3 | $1.64B | Buy |
14,256,048
+65,340
| +0.5% | +$7.53M | 0.03% | 444 |
|
2024
Q2 | $1.95B | Buy |
14,190,708
+429,738
| +3% | +$59.2M | 0.04% | 367 |
|
2024
Q1 | $1.9B | Buy |
13,760,970
+113,079
| +0.8% | +$15.6M | 0.04% | 378 |
|
2023
Q4 | $1.8B | Buy |
13,647,891
+276,493
| +2% | +$36.4M | 0.05% | 368 |
|
2023
Q3 | $1.5B | Sell |
13,371,398
-110,744
| -0.8% | -$12.5M | 0.04% | 396 |
|
2023
Q2 | $1.27B | Buy |
13,482,142
+15,492
| +0.1% | +$1.46M | 0.04% | 461 |
|
2023
Q1 | $1.36B | Buy |
13,466,650
+838,997
| +7% | +$84.9M | 0.04% | 416 |
|
2022
Q4 | $1.51B | Buy |
12,627,653
+580,508
| +5% | +$69.3M | 0.05% | 379 |
|
2022
Q3 | $1.28B | Buy |
12,047,145
+127,555
| +1% | +$13.5M | 0.04% | 408 |
|
2022
Q2 | $1.16B | Buy |
11,919,590
+324,173
| +3% | +$31.6M | 0.04% | 458 |
|
2022
Q1 | $1.09B | Buy |
11,595,417
+118,872
| +1% | +$11.1M | 0.03% | 549 |
|
2021
Q4 | $977M | Buy |
11,476,545
+1,258,312
| +12% | +$107M | 0.02% | 614 |
|
2021
Q3 | $980M | Buy |
10,218,233
+79,736
| +0.8% | +$7.65M | 0.03% | 592 |
|
2021
Q2 | $987M | Sell |
10,138,497
-850,977
| -8% | -$82.8M | 0.03% | 602 |
|
2021
Q1 | $1.07B | Buy |
10,989,474
+3,991,679
| +57% | +$388M | 0.03% | 551 |
|
2020
Q4 | $671M | Buy |
6,997,795
+182,933
| +3% | +$17.5M | 0.02% | 702 |
|
2020
Q3 | $655M | Sell |
6,814,862
-691,828
| -9% | -$66.5M | 0.02% | 608 |
|
2020
Q2 | $916M | Buy |
7,506,690
+551,286
| +8% | +$67.3M | 0.04% | 458 |
|
2020
Q1 | $602M | Buy |
6,955,404
+363,852
| +6% | +$31.5M | 0.03% | 534 |
|
2019
Q4 | $709M | Buy |
6,591,552
+655,434
| +11% | +$70.5M | 0.03% | 610 |
|
2019
Q3 | $535M | Buy |
5,936,118
+277,587
| +5% | +$25M | 0.02% | 699 |
|
2019
Q2 | $478M | Buy |
5,658,531
+163,195
| +3% | +$13.8M | 0.02% | 768 |
|
2019
Q1 | $484M | Buy |
5,495,336
+516,419
| +10% | +$45.5M | 0.02% | 754 |
|
2018
Q4 | $356M | Sell |
4,978,917
-120,359
| -2% | -$8.59M | 0.02% | 867 |
|
2018
Q3 | $627M | Buy |
5,099,276
+16,724
| +0.3% | +$2.06M | 0.03% | 627 |
|
2018
Q2 | $499M | Buy |
5,082,552
+174,057
| +4% | +$17.1M | 0.02% | 730 |
|
2018
Q1 | $407M | Buy |
4,908,495
+132,749
| +3% | +$11M | 0.02% | 827 |
|
2017
Q4 | $371M | Sell |
4,775,746
-81,372
| -2% | -$6.31M | 0.02% | 904 |
|
2017
Q3 | $298M | Buy |
4,857,118
+54,891
| +1% | +$3.36M | 0.02% | 1030 |
|
2017
Q2 | $221M | Sell |
4,802,227
-229,706
| -5% | -$10.6M | 0.01% | 1208 |
|
2017
Q1 | $218M | Buy |
5,031,933
+4,996,784
| +14,216% | +$216M | 0.01% | 1206 |
|
2016
Q4 | $1.36M | Sell |
35,149
-41,659
| -54% | -$1.61M | ﹤0.01% | 1355 |
|
2016
Q3 | $3.89M | Buy |
76,808
+4,569
| +6% | +$231K | 0.01% | 961 |
|
2016
Q2 | $3.28M | Buy |
72,239
+8,247
| +13% | +$375K | ﹤0.01% | 968 |
|
2016
Q1 | $2.53M | Sell |
63,992
-9,408
| -13% | -$372K | ﹤0.01% | 1018 |
|
2015
Q4 | $4.15M | Buy |
73,400
+26,591
| +57% | +$1.5M | 0.01% | 879 |
|
2015
Q3 | $1.86M | Sell |
46,809
-7,337
| -14% | -$292K | ﹤0.01% | 1063 |
|
2015
Q2 | $2.59M | Sell |
54,146
-1,581
| -3% | -$75.5K | ﹤0.01% | 1014 |
|
2015
Q1 | $2.21M | Sell |
55,727
-18,237
| -25% | -$724K | ﹤0.01% | 1043 |
|
2014
Q4 | $1.65M | Sell |
73,964
-38,200
| -34% | -$853K | ﹤0.01% | 1094 |
|
2014
Q3 | $1.76M | Sell |
112,164
-8,900
| -7% | -$139K | ﹤0.01% | 1065 |
|
2014
Q2 | $1.8M | Buy |
121,064
+3,865
| +3% | +$57.4K | ﹤0.01% | 1044 |
|
2014
Q1 | $1.89M | Buy |
117,199
+115,012
| +5,259% | +$1.85M | ﹤0.01% | 1061 |
|
2013
Q4 | $21K | Hold |
2,187
| – | – | ﹤0.01% | 2305 |
|
2013
Q3 | $25K | Hold |
2,187
| – | – | ﹤0.01% | 2137 |
|
2013
Q2 | $29K | Buy |
+2,187
| New | +$29K | ﹤0.01% | 2086 |
|